Brief: Brii Biosciences And OpenBench Announce AI-Driven Collaboration For Proprietary Technology Platform
11/12/2025 12:37
Dec 11 (Reuters) - Brii Biosciences Ltd 2137.HK: BRII BIOSCIENCES AND OPENBENCH ANNOUNCE AI-DRIVEN COLLABORATION FOR PROPRIETARY TECHNOLOGY PLATFORM OPENBENCH - TO RECEIVE PAYMENT FOR DELIVERING NOVEL LEADS THAT MEET SPECIFIC CRITERIA DEFINED BY BRII BIO OPENBENCH - BRII BIO TO GAIN EXCLUSIVE RIGHTS TO LEADS AND CO'S TECHNOLOGY OPENBENCH - COLLABORATION MAY EXPAND TO INCLUDE ADDITIONAL PROGRAMS Source text: ID:nPn8QXT2ya Further company coverage: 2137.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Brii Biosciences
See all newsBrief: BRII Biosciences Discloses Launch Of BRISC, An SIRNA Therapeutics Discovery Platform
China's Brii Biosciences interim net loss narrows on lower R&D expenses
Brief: Brii Biosciences Announces Share Buy-Back Programme No More Than HK$60 Million
Brief: Brii Biosciences Says Arbitration Between Brii And Vir Remains In Early Stages With No Resolution
Brief: Brii Biosciences Submits Demand For Arbitration Against VIR